Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CannaSorb is a water-soluble cannabinoid ingredient developed by Synergy Life Sciences for use in consumer products such as beverages, edibles, and topicals. The flagship version, CannaSorb CB-Active, is derived from GRAS-certified CBD isolate and utilizes a patented chemical conversion process—similar to polysorbate chemistry—to transform fat-soluble cannabinoids into truly water-soluble compounds. This technology enables clear dilution in aqueous solutions and enhances bioavailability and physiological activity compared to standard CBD isolates. It is available as a 100% active liquid or a 50% active flowable powder, and is manufactured in an FDA-audited facility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CannaSorb.